Last reviewed · How we verify
Part 1: Lotion
At a glance
| Generic name | Part 1: Lotion |
|---|---|
| Also known as | Avobenzone, Oxybenzone, Octocrylene |
| Sponsor | Food and Drug Administration (FDA) |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of Head-lice Treatments Elimax Green Lotion and Walgreens Lice Killing Shampoo (NA)
- RTA 408 Lotion in Healthy Volunteers (PHASE1)
- Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Application of Topical BioLexa in Adult Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis (PHASE1)
- Assessment of the Human Systemic Absorption of Sunscreen Ingredients (PHASE1)
- Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer (PHASE2)
- Treatment of Actinic Keratoses (AK) on the Face (PHASE1)
- A Randomized Control Trial of Sun Protection Interventions for Operating Engineers (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |